CMS states that “[f]rom time to time, ASP public files need to be corrected or updated … based on feedback received after the files are published. If CMS receives feedback that necessitates updates to ...

CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket costs at $2 per month for select medications. The initial list includes common ...

While the program could allow private contractors to delay or deny medically necessary care, CMS said it's a way to reduce waste.

After the Centers for Medicare & Medicaid Services (CMS) revealed the list of drugs set to face the first round of price negotiations under the Inflation Reduction Act (IRA), the drugmakers ...

The Save MEDICARE Act is looking to tighten oversight of Medicare Advantage plans.

The Centers for Medicare and Medicaid Services is testing three models to lower the price of drugs, including having a $2 Medicare drug list for about 150 low-cost generics. The Medicare $2 Drug List ...

The negotiations with participating drug companies will occur in 2023 and 2024, and any negotiated prices will become effective beginning in 2026. President Biden released this statement: "When ...

The Stark Law restricts financial relationships between a physician and any entity that furnishes and bills Medicare for DHS (a DHS Entity), and many of the most commonly used Stark Law exceptions ...

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of ...